Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The Sonic Incytes Liver Incyte System, Assessment of Liver Fibrosis and Steatosis

NCT: NCT03957070 · COMPLETED

NCT IDNCT03957070
StatusCOMPLETED
Start Date2019-02-01
Completion2021-04-01
SponsorSonic Incytes (INDUSTRY)
First posted
Last updated

Brief Summary

Evaluate the feasibility of the Liver Incyte system for liver elasticity measurement in healthy volunteers and patients with liver fibrosis. To evaluate the discriminatory ability of elasticity measurements generated by Liver Incyte for healthy volunteers versus patients with liver fibrosis in comparison to FibroScan measurements.

Frequently Asked Questions

What is The Sonic Incytes Liver Incyte System, Assessment of Liver Fibrosis and Steatosis?

The Sonic Incytes Liver Incyte System, Assessment of Liver Fibrosis and Steatosis is a clinical trial registered under NCT03957070. Current status: COMPLETED.

What is the status of NCT03957070?

The current status of NCT03957070 (The Sonic Incytes Liver Incyte System, Assessment of Liver Fibrosis and Steatosis) is: COMPLETED.

When did The Sonic Incytes Liver Incyte System, Assessment of Liver Fibrosis and Steatosis start?

The Sonic Incytes Liver Incyte System, Assessment of Liver Fibrosis and Steatosis started on 2019-02-01.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.